Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial

被引：0
|
作者：
Zahra Darabi
Mina Darand
Zahra Yari
Mehdi Hedayati
Amirhosein Faghihi
Shahram Agah
Azita Hekmatdoost
机构：
[1] Shahid Beheshti University of Medical Sciences,Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute
[2] Shahid Beheshti University of Medical Sciences,Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences
[3] Iran University of Medical Sciences,Colorectal Research Center
来源：
BMC Research Notes | / 12卷
关键词：
Citrulline; NAFLD; Fatty liver; Inflammation; NASH;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial
    Darabi, Zahra
    Darand, Mina
    Yari, Zahra
    Hedayati, Mehdi
    Faghihi, Amirhosein
    Agah, Shahram
    Hekmatdoost, Azita
    [J]. BMC RESEARCH NOTES, 2019, 12 (1) : V
  • [2] Quercetin supplementation in non-alcoholic fatty liver disease A randomized, double-blind, placebo-controlled clinical trial
    Hosseinikia, Mahboobe
    Oubari, Farhad
    Hosseinkia, Roghaye
    Tabeshfar, Zibaneh
    Salehi, Mohammad Gharib
    Mousavian, Zeinab
    Abbasi, Mehrnaz
    Samadi, Mehnoosh
    Pasdar, Yahya
    [J]. NUTRITION & FOOD SCIENCE, 2020, 50 (06): : 1279 - 1293
  • [3] The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: A randomized, placebo-controlled, clinical trial
    Abhari, Khadijeh
    Saadati, Saeede
    Yari, Zahra
    Hosseini, Hedayat
    Hedayati, Mehdi
    Abhari, Shahabeddin
    Alavian, Seyyed Moayyed
    Hekmatdoost, Azita
    [J]. CLINICAL NUTRITION ESPEN, 2020, 39 : 53 - 60
  • [4] Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial
    Mofidi, Fatemeh
    Poustchi, Hossein
    Yari, Zahra
    Nourinayyer, Babak
    Merat, Shahin
    Sharafkhah, Maryam
    Malekzadeh, Reza
    Hekmatdoost, Azita
    [J]. BRITISH JOURNAL OF NUTRITION, 2017, 117 (05) : 662 - 668
  • [5] Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial
    Dabbaghmanesh, Mohammad Hossein
    Danafar, Farideh
    Eshraghian, Ahad
    Omrani, Gholamhossein Ranjbar
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2018, 12 (04) : 513 - 517
  • [6] Nigella sativa and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Results from a randomized, double-blind, placebo-controlled, clinical trial
    Darand, Mina
    Darabi, Zahra
    Yari, Zahra
    Saadati, Saeedeh
    Hedayati, Mehdi
    Khoncheh, Ahmad
    Hosseini-Ahangar, Behnam
    Alavian, Seyed Moayyed
    Hekmatdoost, Azita
    [J]. COMPLEMENTARY THERAPIES IN MEDICINE, 2019, 44 : 204 - 209
  • [7] Combined cranberry supplementation and weight loss diet in non-alcoholic fatty liver disease: a double-blind placebo-controlled randomized clinical trial
    Hormoznejad, Razie
    Shahi, Majid Mohammad
    Rahim, Fakher
    Helli, Bijan
    Alavinejad, Pezhman
    Sharhani, Asaad
    [J]. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION, 2020, 71 (08) : 991 - 1000
  • [8] The effect of nigella sativa supplementation on cardiometabolic outcomes in patients with non-alcoholic fatty liver: A randomized double-blind, placebo-controlled trial
    Rashidmayvan, Mohammad
    Vandyousefi, Sarvenaz
    Barati, Meisam
    Salamat, Shekoufeh
    Ghodrat, Sara
    Khorasanchi, Maryam
    Jahan-Mihan, Alireza
    Nattagh-Eshtivani, Elyas
    Mohammadshahi, Majid
    [J]. COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2022, 48
  • [9] The effects of zinc supplementation on the metabolic factors in patients with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled clinical trial
    Rezaei, Seyed Mohammad Amin
    Mohammadi, Farzaneh
    Eftekhari, Mohammad Hassan
    Ejtehadi, Fardad
    Ghaem, Haleh
    Mohammadipoor, Nazanin
    [J]. BMC NUTRITION, 2023, 9 (01)
  • [10] The effects of zinc supplementation on the metabolic factors in patients with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled clinical trial
    Seyed Mohammad Amin Rezaei
    Farzaneh Mohammadi
    Mohammad Hassan Eftekhari
    Fardad Ejtehadi
    Haleh Ghaem
    Nazanin Mohammadipoor
    [J]. BMC Nutrition, 9
12345